Triomics raises $15M Series A to Revolutionize Cancer Clinical Trials MatchingTriomics raised $15 million in Series A funding to automate cancer clinical trials matching, addressing the critical gap in cancer care.
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunchTriomics uses AI to match cancer patients with clinical trials, saving time for medical staff and increasing patient enrollment.